Perpetua N. Mgbada

Associate
Get in touch

Perpetua is an associate in the firm’s New York office. Her practice focuses on class action, mass tort and other complex litigation involving pharmaceutical product liability.Prior to joining Seeger Weiss in 2007 as an associate, Perpetua worked as a contract attorney with the firm, representing hundreds of class members in mediations and arbitrations against several national life insurance companies. She has also litigated personal injury cases.

  • Practice Areas: Drug Injury, Defective Products, Class Action Claims, Whistleblower Claims, Catastrophic Injury, Toxic Exposure, Personal Injury
  • Email: pmgbada@seegerweiss.com

Perpetua N. Mgbada


Perpetua is an associate in the firm’s New York office. Her practice focuses on class action, mass tort and other complex litigation involving pharmaceutical product liability.Prior to joining Seeger Weiss in 2007 as an associate, Perpetua worked as a contract attorney with the firm, representing hundreds of class members in mediations and arbitrations against several national life insurance companies. She has also litigated personal injury cases.

Bar Admissions

  • New York

MEMBERSHIPS & ASSOCIATIONS

Memberships & Associations

  • New York Bar Association

SELECTED REPRESENTATION

  • In re Yasmin and YAZ Marketing, Sales Practices and Prods. Liab. Litig., MDL No. 2100 (S.D. Ill.). Member of the Seeger Weiss team appointed to the Plaintiffs’ Steering Committee, representing clients against pharmaceutical giant Bayer over severe injuries allegedly resulting from their birth control drugs. The firm was the first to settle clients’ cases, ultimately leading to the creation of nationwide settlement program exceeding $2 billion. Involvement included client intake, case evaluation, discovery, and settlement oversight.
  • In re Pradaxa (Dabigatran Etexilate) Prods. Liab. Litig., MDL 2385 (S.D. Ill.). Represented thousands of patients in consolidated multidistrict litigation (MDL) against Boehringer Ingelheim, claiming that the company’s anticoagulant (blood thinner) drug resulted in severe injuries and death. Helped secured a $650 million Settlement. Involvement included client intake, case evaluation, discovery, and settlement oversight.
  • Pelvic mesh litigation (various). Member of the Seeger Weiss team appointed to the Plaintiffs’ Steering Committee and other leadership positions in several federal MDLs tried in S.D.W. Va.: In re C. R. Bard, Inc., Pelvic Repair System Prods. Liab. Litig., MDL No. 2187; In re American Medical Systems, Inc., Pelvic Repair System Prods. Liab. Litig., MDL No. 2325; In re Boston Scientific Corp. Pelvic Repair System Prods. Liab. Litig., MDL No. 2326; In re Ethicon, Inc. Pelvic Repair System Prods. Liab. Litig., MDL No. 2327; In re Coloplast Corp., Pelvic Support Systems Prods. Liab. Litig., MDL No. 2387; and In re Cook Medical, Inc., Pelvic Repair System Prods. Liab. Litig., MDL No. 2440. Representing thousands of plaintiffs against several large pharmaceutical companies, claiming severe injuries and complications resulting from surgically-implanted transvaginal surgical mesh and bladder slings, designed to help treat Pelvic Organ Prolapse (POP) and Stress Urinary Incontinence (SUI). Involvement includes client intake, case evaluation, and discovery. Cases are in various stages of litigation, with several multimillion-dollar settlements already secured.

FREE CASE EVALUATION

Since its establishment in 1999, Seeger Weiss has led some of the most complex and high-profile litigations in the U.S.